Good Vita / The learning library

TB-500

A name used for a thymosin beta-4 fragment in research-product discussions.

Educational information only. No medical advice or treatment recommendations.

← Back to the full library

Research compounds Evidence gaps identified Recovery research

Also discussed as: Thymosin beta-4 fragment, LKKTETQ

What it is and how it works

This profile follows the FDA’s identity description: the thymosin beta-4 fragment LKKTETQ, also called TB-500. A fragment is a different molecular entity from full-length thymosin beta-4. Research on one should not silently become a claim about the other.

Source for the mechanism context →

A closer look at the cited evidence

Evidence gaps identified

This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.

Study or assessment
FDA — TB-500 fragment safety assessment
Design
Regulatory safety assessment, not an efficacy trial.
Who or what was studied
No human drug-exposure evidence identified in the cited FDA entry.
What was observed
The cited assessment identifies a human evidence gap for the fragment.
Limits of interpretation
It cannot establish healing effectiveness or a complete adverse-effect profile.
Read the cited study or assessment →

What the evidence means

Findings about a full-length molecule cannot automatically establish effects of a fragment or a marketed product.

Approval and regulatory context

Not an FDA-approved recovery medicine. Product names may obscure differences in molecular identity.

Safety and uncertainty

Human exposure data are lacking.

What remains uncertain

Molecular identity is an essential first question: a shared marketing name is insufficient. Reliable human research on the exact fragment and formulation would be needed before clinical claims could be assessed.

These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.

Sources behind this overview

Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.

Choose your next step

From a question to a better-informed conversation.

Use the learning resources in the order that helps you. No product selection, dosing, or treatment recommendations.

Where wellness coaching fits—and where medical care begins

Start Your Assessment